More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary Kannaway® to Hold Final Exclusive Red-Carpet Event of 2017 in Melville, NY Showcasing Company’s Hemp Oil Lifestyle Products

Medical Marijuana, Inc. Subsidiary Kannaway® to Hold Final Exclusive Red-Carpet Event of 2017 in Melville, NY Showcasing Company’s Hemp Oil Lifestyle Products

by adminAdrianRamirez | Sep 27, 2017 | Kannaway, Press Releases

SAN DIEGO, Sept. 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding its last Exclusive Red-Carpet Event of 2017 in Melville,...
El Dictamen Profiles one of First Patients Granted CBD Oil in Mexico

El Dictamen Profiles one of First Patients Granted CBD Oil in Mexico

by adminAdrianRamirez | Sep 27, 2017 | HempMeds Brasil, Media Coverage

A recent article on El Dictamen explored the story of a little girl named Alina, one of the first patients in Mexico to be approved for a CBD oil treatment. An article this week in Mexico’s El Dictamen details Alina and her family’s story, revealing how discovering...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Sponsor 8th ABN-RJ/ANERJ Congress in Rio de Janeiro

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Sponsor 8th ABN-RJ/ANERJ Congress in Rio de Janeiro

by adminAdrianRamirez | Sep 26, 2017 | HempMeds Brasil, Press Releases

SAN DIEGO, Sept. 26, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is proud to sponsor the 8th Brazilian Academy of Neurology/Association of Neurology...
Dr. Stuart Titus and Raul Elizalde Interviewed as Part of Union-Tribune Community Spotlight

Dr. Stuart Titus and Raul Elizalde Interviewed as Part of Union-Tribune Community Spotlight

by adminAdrianRamirez | Sep 25, 2017 | HempMeds Mexico, Media Coverage

HempMeds® Mexico and parent company Medical Marijuana, Inc. featured in extended interview on the state of medical cannabis in Mexico and around the world. Medical Marijuana, Inc. President and CEO Dr. Stuart Titus was joined by Raul Elizalde, President of HempMeds®...
Telemundo Visits Medical Marijuana, Inc. Offices to Learn More About RSHO™ in Mexico

Telemundo Visits Medical Marijuana, Inc. Offices to Learn More About RSHO™ in Mexico

by adminAdrianRamirez | Sep 22, 2017 | HempMeds Mexico, Media Coverage

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company and its flagship brand RSHO™ were featured in recent Telemundo piece about government’s purchase of CBD oil. [/vc_column_text][vc_video...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.